3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus
Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a single center study of patients with inactive or mild SLE being performed to
determine the safety, tolerability, and pharmacodynamics of DIM.